Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140348821A1
SERIAL NO

14286796

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods of testing to identify and to treat a subset of colon cancer patients exhibiting dMMR tumor tissue, who derive significant clinical benefit from the addition of bevacizumab to standard adjuvant chemotherapy. The presence of a V600E BRAF mutation is also of significance.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NSABP FOUNDATION INCFOUR ALLEGHENY CENTER 5TH FLOOR PITTSBURGH PA 15212

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Paik, Soonmyung Pittsburgh, US 36 780
Pogue-Geile, Katherine Lea Pittsburgh, US 4 130

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation